ProAssurance Announces Results from 2023 Annual Meeting of Shareholders and Review of Capital Management Strategy
26 Mayo 2023 - 8:15AM
Business Wire
ProAssurance Corporation (NYSE:PRA) on May 24th held its Annual
Meeting of Shareholders. As a result of voting on the matters
placed before the shareholders at the Annual Meeting, the company’s
four director nominees were re-elected to three-year terms, and
shareholders ratified the selection of Ernst & Young, LLP as
our independent auditing firm for the fiscal year ending December
31, 2023.
Acting on matters related to compensation, shareholders
approved, on an advisory basis, the compensation of our named
executive officers for 2022. Also on an advisory basis,
shareholders approved the proposal to hold the advisory vote on the
compensation of our named executive officers yearly. All proposals
on the ballot were approved by a substantial supermajority of votes
cast.
The Company continually evaluates how best to return capital to
shareholders. In light of the current trading price of its shares,
the Company announced today that its Board of Directors has
suspended the Company’s quarterly cash dividend. Instead, the
Company intends to utilize its existing share repurchase
authorization to return capital to shareholders.
About ProAssurance
ProAssurance Corporation is an industry-leading specialty
insurer with extensive expertise in healthcare professional
liability, products liability for medical technology and life
sciences, legal professional liability, and workers’ compensation
insurance. ProAssurance Group and its operating subsidiaries are
rated “A” (Excellent) by AM Best; ProAssurance and its operating
subsidiaries are rated “A-” (Strong) by Fitch Ratings.
For the latest on ProAssurance and its industry-leading suite of
products and services, cutting-edge risk management and practice
enhancement programs, follow @ProAssurance on Twitter or LinkedIn.
ProAssurance’s YouTube channel regularly presents thought
provoking, insightful videos that communicate effective practice
management, patient safety and risk management strategies.
Caution Regarding Forward-Looking Statements
Any statements in this news release that are not historical
facts are specifically identified as forward-looking statements.
These statements are based upon our estimates and anticipation of
future events and are subject to significant risks, assumptions and
uncertainties that could cause actual results to differ materially
from the expected results described in the forward-looking
statements. Forward-looking statements are identified by words such
as, but not limited to, “anticipate,” “believe,” “estimate,”
“expect,” “hope,” “hopeful,” “intend,” “likely,” “may,”
“optimistic,” “possible,” “potential,” “preliminary,” “project,”
“should,” “will,” and other analogous expressions.
Although it is not possible to identify all of these risks and
factors, they include, among others, the following: inadequate loss
reserves to cover the Company's actual losses; inherent uncertainty
of models resulting in actual losses that are materially different
than the Company's estimates; adverse economic factors; a decline
in the Company's financial strength rating; loss of one or more key
executives; loss of a group of agents or brokers that generate
significant portions of the Company's business; failure of any of
the loss limitations or exclusions the Company employs, or change
in other claims or coverage issues; adverse performance of the
Company's investment portfolio; adverse market conditions that
affect its excess and surplus lines insurance operations; and other
risks described in the Company's filings with the Securities and
Exchange Commission. These forward-looking statements speak only as
of the date of this release and the Company does not undertake and
specifically declines any obligation to update or revise any
forward-looking information to reflect changes in assumptions, the
occurrence of unanticipated events, or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230526005089/en/
For More Information: Jason Gingerich, VP, Investor Relations
800-282-6242 • 512-879-5101 • JasonGingerich@ProAssurance.com
ProAssurance (NYSE:PRA)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
ProAssurance (NYSE:PRA)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024